Document is current

Any future updates will be listed below

Cost-utility analysis of factor VIII diet therapies prepared using blood plasma vs. recombinant technique for patients with hemophilia A

Crossref DOI link: https://doi.org/10.1007/s40199-020-00347-8

Published Online: 2020-04-22

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark